Barlow Wealth Partners Reduces its MercadoLibre Stake to Nearly Nothing

Barlow Wealth Partners cut its MercadoLibre stake by 8,312 shares in Q1 2026, a trade valued at about $16.03 million, leaving just 430 shares worth $798,007 at quarter-end. The position fell to 0.09% of AUM from 2.1% previously, reducing its weight by 1.78% of firm AUM and pushing it out of the fund’s top five holdings. The article frames the sale as a possible caution on margins, though the move is primarily a portfolio-positioning update rather than a fundamental catalyst.

Analysis

The important signal is not the sale itself, but the collapse in portfolio conviction: a near-elimination of a previously meaningful position implies the manager sees a much weaker forward information ratio than the headline growth story suggests. That matters because MELI has become more market-sensitive as it scales; when a high-multiple compounder loses sponsorship, the first-order price reaction can be modest, but the second-order effect is multiple compression as incremental buyers start demanding proof of margin durability rather than just revenue momentum.

The core debate is margin quality versus growth longevity. If financing and logistics remain strategically subsidized to defend ecosystem share, near-term earnings power can stay under pressure even while operating metrics look healthy; that is a classic setup where consensus extrapolates gross merchandise and revenue growth, while the market ultimately prices in lower terminal margins and higher credit risk. In that sense, the real downside catalyst is not weaker sales, but a prolonged period where capital intensity and funding costs keep free cash flow below what a premium LATAM platform should generate.

Competitively, any hesitation in MELI's aggressiveness gives room to regional e-commerce, payments, and merchant-acquiring peers to defend take rates and customer acquisition economics. The less obvious beneficiary is not a single rival, but the broader basket of global platform names with cleaner margin trajectories and lower credit exposure; relative performance can favor U.S. mega-cap compounders if investors rotate out of names where growth still depends on subsidized balance-sheet expansion. If MELI re-accelerates operating margin expansion over the next 1-2 quarters, this pullback in ownership will likely prove wrong; if not, the de-rating can persist for months even with solid revenue growth.

Contrarianly, the market may already be overly focused on margin compression and underappreciating the option value of Latin American financial deepening. Penetration is still early, so even modest improvements in deposit stickiness and credit losses could lift earnings power disproportionately over a 12-24 month horizon. The right framing is that this is a quality-vs-execution trade, not a secular-growth unwind.

Key Decisions for Investors

• Trim MELI into strength over the next 2-4 weeks if the stock rallies on no new margin data; use the position reduction as a sentiment warning and prefer to re-enter only after evidence of operating margin stabilization.
• Express a relative-value short MELI / long GOOGL or MSFT pair for 1-3 months if you want to isolate multiple compression risk against cleaner free-cash-flow compounding; target downside in MELI from de-rating rather than absolute market beta.
• If willing to stay constructive, buy MELI on a pullback only after the next earnings call confirms that margin pressure is transitory; structure with calls or call spreads to limit downside given execution risk.
• Monitor credit-loss disclosures and take-rate trends as the key reversal catalysts over the next 1-2 quarters; a re-acceleration there would argue for covering any short or adding back exposure quickly.
• For broader fintech exposure, prefer V over MELI near term as a lower-volatility beneficiary of digital payments adoption without the balance-sheet and emerging-market execution risk.